ADSL and cystic fibrosis: Peptide antibacterial pro-drugs were recently administered into the lungs using a vibrating mesh nebulizer, suggesting that the pro-drug modification is not harmful [20] and supporting further development of pro-AMPs as therapeutics in CF.